The survival analysis showed that younger age; IDH-1 mutations; higher albumin, AGR, and PNI levels; and lower NLR, PLR, and fibrinogen levels were favorable prognostic factors of OS in all gliomas and glioblastomas (GBMs) (Table 2). This evidence concerns the gene IDH1 and glioblastoma.